《大行報告》花旗下調世茂集團(00813.HK)目標價至4.5元 評級「中性」
花旗發表評級報告指,由於世茂集團(00813.HK)延遲刊發2021年全年業績,故在4月1日起停牌,公司已收到聯交所復牌指引,而集團負上主要責任制定復牌行動計劃,包括刊發上市規則規定的所有尚未發佈的財務業績、就前任核數師羅兵鹹永道於辭任函中提出的事項進行適當的獨立調查、進行獨立內部監控檢閱並證明公司已設立充分的內部監控及程序等。
該行表示,將其風險評級更改爲高風險,維持其評級爲「中性」。基於銷量預測降低,將公司2021年至23年每股盈測下調57%至65%,將其目標價由5.7元下調至4.5元。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.